“Marrow Asleep or Awake?”: William Aird Simplifies Anemia Diagnosis
William Aird, Professor of Medicine at Harvard Medical School, posted on X:
՛՛1/4
RETIC COUNT
When evaluating anemia, I teach my trainees to start with a simple binary:
Is the bone marrow responding appropriately or not?
That answer lies in a single number: the absolute reticulocyte count (ARC).
2/4
- ARC < 0.12 ×10⁶/µL → hypoproliferative (marrow asleep).
- ARC ≥ 0.12 ×10⁶/µL → hyperproliferative (marrow awake).
It’s a light switch, not a dimmer.
Once the marrow’s “on,” the next question isn’t how high, but why.
3/4
Getting granular (0.15 vs 0.20) adds math, not meaning.
At that point, you’ve already learned the key thing:
the marrow can respond, so look for blood loss or hemolysis, not marrow failure.
4/4
Clinical reasoning often starts binary and gets nuanced later (i.e., decision thresholds are categorical).
The ARC is one of those places where simple still works.
Below 0.12 → asleep.
Above 0.12 → awake.
Everything else is physiology, not management.՛՛
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology
-
Sep 23, 2026, 13:04Ben Samelson-Jones: Do Gene Variants Drive PK Differences in FIX-Fusion and N9-GP Therapies?
-
Sep 23, 2026, 12:57Shelly Reed: Advocating for HTCs and CDC Funding with the Hemophilia Federation of America